Y-k Kang
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Health-related quality of life with bemarituzumab plus mFOLFOX6 in patients with FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer.
Journal: ESMO gastrointestinal oncology
Published: October 08, 2024
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 15, 2023
Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 30, 2023
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 20, 2023
Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A.
Journal: ESMO open
Published: June 08, 2022
Safety and efficacy of HER2 blockade by trastuzumab-based chemotherapy-containing combination strategies in HER2+ gastroesophageal adenocarcinoma.
Journal: ESMO open
Published: October 08, 2021
Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 23, 2021
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 07, 2020
A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer.
Journal: British journal of cancer
Published: January 22, 2014
Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib.
Journal: British journal of cancer
Published: June 10, 2013
Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer.
Journal: British journal of cancer
Published: April 21, 2012
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum.
Journal: British journal of cancer
Published: February 21, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026